Teva names Erez Vigodman new CEO

"I understand the challenges facing Teva and I am confident that, together with the management team, we can address these challenges and deliver on our commitment to creating value for our shareholders by expanding Teva's businesses and delivering long-term growth," Vigodman said in a statement.
Vigodman will fill the roles left vacant in late October by his predecessor Jeremy Levin's ouster. Levin was pushed out of the position less than 18 months in over disagreements on the company's strategy.
The 54-year-old currently serves as CEO of Makhteshim Agan Industries (MAI), the world’s leading generic agrochemical company, where he will remain until February 6. Prior to that, he served as the Strauss Group's CEO.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy